|Other Names||Vesicle transport protein USE1, Putative MAPK-activating protein PM26, USE1-like protein, p31, USE1, USE1L|
|Format||Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||SNARE that may be involved in targeting and fusion of Golgi- derived retrograde transport vesicles with the ER.|
|Cellular Location||Endoplasmic reticulum membrane; Single-pass type IV membrane protein|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
SNARE that may be involved in targeting and fusion of Golgi-derived retrograde transport vesicles with the ER.
Aoki, T., et al. Mol. Biol. Cell 20(11):2639-2649(2009)Okumura, A.J., et al. J. Biol. Chem. 281(7):4495-4506(2006)Nakajima, K., et al. EMBO J. 23(16):3216-3226(2004)Hirose, H., et al. EMBO J. 23(6):1267-1278(2004)Matsuda, A., et al. Oncogene 22(21):3307-3318(2003)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.